tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Raghuram Selvaraju, 1365 are a BUY (94.2%), 79 are a HOLD (5.45%), 5 are a SELL (0.35%).
Analyst Raghuram Selvaraju, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 36.58% that have a potential upside of 46.21% achieved within 198 days.
Raghuram Selvaraju’s has documented 2,613 price targets and ratings displayed on 149 stocks. The coverage is on Healthcare, Basic Materials, Consumer Defensive, Technology, Utilities, Consumer Cyclical, Communication Services sectors.
Most recent stock forecast was given on BTAI, BioXcel Therapeutics at 02-Apr-2026.
Analyst best performing recommendations are on RAPT (RAPT THERAPEUTICS).
The best stock recommendation documented was for MBOT (MICROBOT MEDICAL) at 12/24/2019. The price target of $12 was fulfilled within 3 days with a profit of $4.28 (26.29%) receiving and performance score of 87.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Apr-2021
1 years 9 months 17 days ago
(20-Jun-2024)
12/26 (46.15%)
$-53.8 (-84.33%)
1398
Sell Since 06-May-2022
2 years 4 months 17 days ago
(20-Nov-2023)
0/2 (0%)
$1519.2 (1880.20%)
Buy Since 25-Oct-2023
$20
$5.26 (35.69%)
2 years 5 months 12 days ago
(25-Oct-2023)
1/17 (5.88%)
$5.8 (40.85%)
77
Hold Since 19-Jul-2023
$25
$10.26 (69.61%)
2 years 8 months 18 days ago
(19-Jul-2023)
1/2 (50%)
$3.4 (15.74%)
175
Buy Since 25-Sep-2018
$1200
$1185.55 (8204.50%)
3 years 11 months 1 days ago
(05-May-2022)
1/9 (11.11%)
$1173 (4344.44%)
9
Which stock is Raghuram Selvaraju is most bullish on?
Which stock is Raghuram Selvaraju is most reserved on?
What Year was the first public recommendation made by Raghuram Selvaraju?
